Infants and children with PWS should start with a daily dose of 0.5 mg/m2·d with subsequent adjustments toward 1.0 mg/m2·d according to clinical response and be guided by maintenance of physiological levels of insulin like growth factor 1 (IGF-1). Here, IGF1 is linked to Prader-Willi syndrome.